HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alberto Roggi Selected Research
Alberto Roggi Research Topics
Disease
6
Tuberculosis (Tuberculoses)
01/2021 - 01/2014
2
Hearing Loss (Hearing Impairment)
01/2021 - 06/2020
2
Ototoxicity
01/2021 - 06/2020
1
Coinfection
06/2020
1
Extensively Drug-Resistant Tuberculosis
01/2014
Drug/Important Bio-Agent (IBA)
3
Rifampin (Rifampicin)
FDA Link
Generic
01/2021 - 01/2020
2
Linezolid (Zyvox)
FDA Link
01/2021 - 01/2014
2
Lopinavir
FDA Link
06/2020 - 01/2020
2
Rifabutin (Ansamycin)
FDA Link
06/2020 - 01/2020
2
Ritonavir (Norvir)
FDA Link
06/2020 - 01/2020
1
Kanamycin
FDA Link
06/2020
1
lopinavir-ritonavir drug combination (Kaletra)
FDA Link
01/2020
1
pretomanid
IBA
01/2014
1
Fluoroquinolones
IBA
01/2014
1
bedaquiline (R207910)
IBA
01/2014
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2014
1
OPC-67683
IBA
01/2014
Therapy/Procedure
3
Injections
01/2021 - 01/2014